Article · 2013
Editorial Board Member
Esma S Yolcu
Institute for Cellular Therapeutics, University of Louisville, USA
About
As published by the journal they serve.
Dr. Esma S. Yolcu is Assistant Professor of Microbiology and Immunology, Director of Imaging Facility at the Institute for Cellular Therapeutics, and member of James Brown Cancer Center, University of Louisville, Louisville, KY. After receiving her Ph.D. from University of Ankara, Turkey, she joined the Institute for Cellular Therapeutics at the University of Louisville to pursue her postdoctoral training followed by promotion to a faculty position in the Department of Microbiology and Immunology. Dr. Yolcu’s research focuses on the modulation of the immune system for the treatment of autoimmunity and graft rejection. Her work has been funded by various federal and nonfederal funding agencies, including NIH, American Heart Association, and American Diabetes Association. Dr. Yolcu is the recipient of several awards, member of various national and international societies, serves on Editorial Board of two scientific journals, and published over 67 peer-reviewed papers, abstracts, and review articles in high ranking journals, such as Immunity, Circulation, and Journal of Immunology.
Research interests
Journals they serve
The seats these journals name them in.
- Journal of Clinical and Cellular ImmunologyEditorial Board Member
Articles we hold
Articles in the journals they serve whose byline carries this name.
Article · 2012
Establishment of allogeneic mixed chimerism using bone marrow cells engineered to display on their surface an exogenous FasL protein with potent apoptotic activity
Article · 2012
The Promise of PD-1 Signaling Pathway for Cancer Immunotherapy
Article · 2018
Engineering bone marrow cells with an immunomodulatory protein for the prevention of graft-vs-host disease
Article · 2018
Pancreatic islets engineered with a chimeric PD-L1 protein overcome rejection in allogeneic recipients
Article · 2018
Engineering bone marrow cells with an immunomodulatory protein for the prevention of graft-vshost disease
Article · 2016
Mechanistic basis of allotolerance induced by SA-FasL-engineered pancreatic islets
Article
Negative vaccination with donor splenocytes engineered with FasL as an effective mean of inducing transplantation tolerance
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.